Certrorelix Acetate Injection 0.25mg Certifert

The acetic acid salt of Certrorelix Acetate Injection is called cetrorelix acetate. It is a gonadotrophin-releasing hormone (GnRH) antagonist used to treat breast and prostate cancers that are hormone-sensitive as well as infertility. In addition to being antineoplastic, it functions as a GnRH antagonist.

Cetrorelix functions by blocking premature egg release (premature ovulation). During regulated ovarian stimulation, cetrorelix is used to avoid early ovulation. Other uses for cetrorelix not covered in Certrorelix Acetate Injection guide are possible.

Conclusion. The number of oocytes recovered or the pregnancy rate were not significantly different when the dose of cetrorelix used in the antagonist protocol was decreased.

• Serious adverse effects of cetrotide include stomach pain
• bloating
• nausea
• vomiting
• diarrhoea
• rapid weight gain
• especially in the face and belly
• little to no urination, pain when you breathe, and more.

To know more click here

During the early- to mid-follicular phase, Cetrotide® (cetrorelix acetate for injection) 0.25 mg may be injected subcutaneously once daily. On either stimulation day 5 (morning or evening) or day 6 (morning), cetrotide® 0.25 mg is given, and it is continued daily until the day of hCG Certrorelix Acetate Injection

Cetrotide® delays the LH surge and, as a result, ovulation in women in a dose-dependent manner. At the doses employed during controlled ovarian stimulation, FSH levels are not impacted. The duration of effect of Cetrotide® after a single 3 mg dose has been confirmed to be at least 4 days.

Cetrotide is designed to provide 4 days of suppression after a single 3 mg dose (no LH surge for 96 hours). The daily 0.25mg Cetrotide injections are given until the stimulation is finished and the HCG is administered if the patient requires longer days of stimulation than the required 96 hours.

When using urinary or recombinant gonadotropins, treatment with cetrotide should begin on days 5 or 6 of ovarian stimulation (roughly 96 to 120 hours after the start of ovarian stimulation). Cetrotide treatment should continue throughout the gonadotropin treatment period, including the day of ovulation.

A gonadotropin-releasing hormone having antagonistic (blocking) activity is called cetrotide (cetrorelix). When women are undergoing controlled ovarian stimulation, cetrotide is used to avoid early ovulation and an increase in LH (luteinizing hormone).

if you’re looking for a product or brand, Click here.